Department of Neurosurgery and the McKnight Brain Institute, University of Florida, USA.
Exp Neurol. 2013 Jun;244:59-66. doi: 10.1016/j.expneurol.2012.01.004. Epub 2012 Jan 13.
Neural stem cells and neural progenitors (NSC/NPs) hold great promise in neuro-restorative therapy due to their remarkable capacity for self-renewal, plasticity, and ability to integrate into host brain circuitry. Some types of epilepsy would appear to be excellent targets for this type of therapy due to known alterations in local circuitry based on loss or malfunction of specific types of neurons in specific brain structures. Potential sources for NSC/NPs include the embryonic blastocyst, the fetal brain, and adult brain and non-neural tissues. Each of these cell types has potential strengths and weaknesses as candidates for clinical therapeutic agents. This article reviews some of the major types of NSC/NPs and how they have been studied with regard to synaptic integration into host brain circuits. It also reviews how these transplanted cells develop and interact with host brain cells in animal models of epilepsy. The field is still wide open with a number of very promising results but there are also some major challenges that will need to be addressed prior to considering clinical applications for epilepsy.
神经干细胞和神经祖细胞(NSC/NPs)由于其自我更新、可塑性以及整合到宿主大脑回路的能力,在神经修复治疗中具有巨大的应用前景。由于特定脑结构中特定类型神经元的缺失或功能障碍导致局部回路的已知改变,某些类型的癫痫似乎是这种治疗类型的理想靶点。NSC/NPs 的潜在来源包括胚胎囊胚、胎儿大脑和成人大脑以及非神经组织。作为临床治疗药物候选物,每种细胞类型都有其潜在的优势和弱点。本文综述了一些主要类型的 NSC/NPs 及其在宿主大脑回路突触整合方面的研究进展。还综述了这些移植细胞在癫痫动物模型中的发育和与宿主脑细胞相互作用的情况。该领域仍有许多非常有前途的结果,但也存在一些重大挑战,在考虑将其应用于癫痫的临床治疗之前,需要解决这些挑战。